Digest Network Come funziona
Network
/
Società
Vi
Non verificato

Virion Therapeutics, LLC

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaIndustriaSalute

2 comunicati stampa

Guarda tutti i comunicati
09/11/2025
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Medicina - Varie
Industria
Eventi
Virion Therapeutics Reports Progress Towards HBV Functional Cure with Sustained and Continued HBsAg Declines up to One Year After a Single VRON-0200 Dose From its Phase 1b Study at AASLD’s The Liver Meeting® 2025
Fonte
Virion Therapeutics, LLC
Emittente
Business Wire
1.00
0
07/10/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Industria
Virion Therapeutics Announces Upcoming Clinical Presentation Highlighting VRON-0200 Study Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2025
Fonte
Virion Therapeutics, LLC
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0